Drug Type Small molecule drug |
Synonyms Humylub PF |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Dry Eye Syndromes | Phase 1 | MX | 17 Jul 2017 | |
Hypersensitivity | Preclinical | MX | 17 Jul 2017 | |
Mallory-Weiss Syndrome | Preclinical | MX | 17 Jul 2017 |
Phase 4 | 326 | (PRO-087 PF) | oeaghmpywo(autwbotutj) = lxjkwwmetw qxzrzmorsr (zhevopwymb, xxnftsnpfl - haslthekki) View more | - | 31 Oct 2019 | ||
(Systane Ultra) | oeaghmpywo(autwbotutj) = hfudiyybsw qxzrzmorsr (zhevopwymb, gyfbmkdxif - fskchwpzze) View more | ||||||
Phase 1 | 30 | (PRO-087) | ufeyjmqifm(mlozwqqktb) = aydzucffns ekvlthznnh (vthganhdhb, indcockkic - gmnmziugrf) View more | - | 19 Jul 2019 | ||
(Xyel Ofteno) | ufeyjmqifm(mlozwqqktb) = qhurimeviu ekvlthznnh (vthganhdhb, aedhqywgnf - vbjmjlnxuy) View more |